We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CTI OPAXIO™ Receives Orphan Drug Designation for Malignant Brain Cancer from FDA

News   Oct 09, 2012

 
CTI OPAXIO™ Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
 
 
 

RELATED ARTICLES

Obesity Linked to Increased Risk of Early-Onset Colorectal Cancer

News

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

READ MORE

Novel Way to Generate Molecules for Drug Development

News

Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.

READ MORE

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE